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According to Oron et al. [FEBS Lett. (1980) 118, 255-2581, nuclear glycogen synthase represents an 
artifact of preparation in rat liver nuclei. We investigated the nuclei isolated from in vitro growing HD33 
ascites cells with exclusively cytoplasmic, and from in vivo growing HD33 Ehrlich-Lettre ascites tumor 
cells with mainly intranuclear, glycogen deposition. Biochemical and ultracytochemical analyses revealed 
the complete absence of any contamination of the isolated nuclei by cytoplasmic glycogen particles and 
associated glycogen synthase activity. The glycogen synthase residing in isolated nuclei of in vivo growing 
HD33 ascites tumor cells represents a truly nuclear enzyme activity 
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1. INTRODUCTION 
Conflicting reports have been published on the 
occurrence of glycogen synthase activity in mam- 
malian cell nuclei. On the one hand, glycogen syn- 
thase activity in damaged nuclei isolated from li- 
vers of normal and diabetic rats was characterized 
as an artifact of preparation and considered as a 
useful criterion for the degree of the damage [l]. 
On the other, intact nuclei isolated from HD33 
Ehrlich-Lettre ascites tumor (ELAT) cells were 
shown to possess high autochthonous glycogen 
synthase activity [2]. Both reports, however, em- 
phasize the necessity to exclude, in studies on nu- 
clear glycogen synthase, any contamination of iso- 
lated nuclei by cytoplasmic glycogen particles 
and/or associated glycogen synthase activity. 
particles and associated enzyme activity could be 
safely avoided. Furthermore, glycogen synthase 
present in isolated nuclei of in vivo growing HD33 
ascites tumor cells was found to be unrelated to 
cytoplasmic glycogen deposition and represents a 
truly nuclear enzyme activity. 
2. MATERIALS AND METHODS 
Using in vitro growing HD33 ascites cells, which 
exhibit a pronounced but exclusively cytoplasmic 
glycogen storage, we examined the degree to which 
such contamination can be prevented. Biochemical 
and cytochemical data presented here indicate 
that, by carefully applying adequate procedures 
for isolating nuclei from those cells, any con- 
tamination of the nuclei by cytoplasmic glycogen 
These results were presented in part at the Annual 
Meeting of The Deutsche Gesellschaft fur Zellbiologie, 
Munich, 18-20 March 1982 (abst. Eur. J. Cell Biol. 
(1982) 27, 16) 
In vitro cells of the strain HD33 were kept in 
suspension culture as in [3] and harvested in the 
late exponential phase of growth. The originally 
existing ability of the cells to store nuclear 
glycogen [4] had been completely lost during sev- 
eral years of in vitro propagation, resulting in ex- 
clusively cytoplasmic glycogen deposition. In vivo 
cells of the HD33 ELAT subline were handled as 
in (21 but harvested on day 4 of tumor growth. At 
this stage, the majority of the tumor cells contains 
relatively small, almost exclusively nuclear 
glycogen deposits. 
The preparation and fractionation of cells grown 
in vitro and in vivo, the assaying of glycogen syn- 
thase, and the determination of protein and 
glycogen content were performed as in [2]. The 
sources of chemicals, sera, reagents and radio- 
chemicals were as in ]2, 31; osmium tetroxide was 
obtained from Degussa (Hanau), Epon 812 from 
Serva (Heidelberg) and phosphotungstic acid 
Published by Elsevier Biomedical Press 
00145793/82/OOOt-OOOOooo/$2.75 @ 1982 Federation of European Biochemical Societies 207 
Volume 147, number 2 FEBS LETTERS October 1982 
(PTA) from Merck (Darmstadt). 3. RESULTS 
For electron microscopy, whole cells and iso- 
lated nuclei were fixed simultaneously with glu- 
taraldehyde/osmium tetroxide [5] which, in our 
hands, gave the best conservation of glycogen. 
After post-fixation in 2% aqueous osmium tetrox- 
ide and dehydration in graded steps of ethanol, the 
material was embedded in Epon 8 12. 
For the cytochemical demonstration of glyco- 
gen, a modification of the PTA-staining method [6] 
was used (in preparation). Briefly, ultrathin sec- 
tions on Formvar-coated grids were immersed in 
3% hydrogen peroxide for lo-30 min, and floated 
for 5-8 min on a 1% PTA solution made up in 
1 N HCl (pH 1.0). After that staining procedure, 
the grids were rinsed for lo-20 s in distilled water, 
and air dried. Electron micrographs were obtained 
with a Zeiss EM 10 A electron microscope oper- 
ated at 60 or 80 kV. 
In vitro grown HD33 ascites cells contain large, 
cytoplasmic deposits of glycogen particles. The lat- 
ter are completely absent from the nuclei (lig.la). 
In preparations of isolated nuclei, glycogen parti- 
cles could be detected neither inside, nor attached 
to, nor outside of the nuclei (lig.lb). Isolated nu- 
clei with damaged nuclear envelope were free of 
glycogen particles, too. The only cytoplasmic struc- 
tures found in preparations of isolated nuclei were 
cytoplasmic invaginations typical for ascites cell 
nuclei, and some remnants of the endoplasmic re- 
ticulum connected to the nuclear envelope without 
associated glycogen particles. 
In in vivo grown HD33 ELAT cells from an ear- 
ly stage of tumor development, glycogen is ac- 
cumulated almost exclusively within the nuclei 
(lig.2a). Cytoplasmic glycogen deposits can hardly 
Fig.1. HD33 cells and isolated nuclei after PTA staining, resulting in a selective, intensely black staining of glycogen 
particles; the other cellular constituents remain unstained: (a) HD33 ascites cells grown in vitro with large cytoplasmic 
deposits of glycogen (some are denoted by an asterisk); (b) nuclei isolated from the cells shown in (a) (note the 
complete absence of heavily stained glycogen particles). 
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Fig.2. HD33 cells and isolated nuclei after PTA staining, resulting in a selective, intensely black staining of glycogen 
particles; the other cellular constituents remain unstained: (a) In vivo grown HD33 ELAT cell 4 days after transplanta- 
tion with a nuclear deposit of glycogen a-particles, demarcated by arrows (C, cytoplasm; N, nucleus); (b) nucleus 
isolated from a cell as shown in fig.2a. Conformation and intranuclear localization of glycogen deposits remain un- 
changed after the isolation procedure. Insert: Glycogen particles from an isolated nucleus at high magnification 
(40 000 x ); N, nucleus. 
be found. In situ, as well as after isolation, nuclear 
deposits of glycogen a-particles are surrounded by 
chromatin (fig.2b); the isolation procedure caused 
no detectable dislocation of the deposits. No 
glycogen particles were found attached to or out- 
side the nuclei isolated from in vivo grown ascites 
tumor cells. 
In summary, the ultracytochemical examination 
of PTA-stained whole cells and isolated nuclei re- 
veals, in both cell types, an adequate isolation of 
the nuclei without detectable contamination by 
cytoplasmic glycogen particles, and demonstrates 
that the preexisting nuclear glycogen deposits of 
HD33 ELAT cells are not altered morp.hologically 
in the course of the isolation procedure. 
The ultrastructural observations are in full 
agreement with biochemical data on glycogen con- 
tent and glycogen synthase activity of whole cells 
Table I 
Subcellular distribution of glycogen and glycogen synthase activity in HD33 cells 
Growth 
conditions 
Cell fraction Glycogen content Glycogen synthase (a + b)- 
[pg/mg protein]a form [mU/mg proteinla 
In vitro Isolated nuclei 0 
Cytoplasmb 1770 
Cell homogenate 967 
In vivo Isolated nuclei 41 
Cell homogenate 24 
aMean values of 2-6 expt; Qytoplasm is defined as in [2] 
0 
34.2 
14.4 
12.7 
4.7 
209 
Volume 147, number 2 FEBSLETTERS October 1982 
and isolated nuclei (table 1). The highest total 
glycogen synthase activity was determined in the 
glycogen-rich cytoplasm of the in vitro grown cells. 
Preparations of nuclei isolated from these cells 
contained no detectable glycogen and did not in- 
corporate UDP-[14C]glucose into glycogen in the 
presence of 6.67 mM Glc-6-P even during pro- 
longed incubation for up to 30 min at 30°C. High- 
er concentrations of Glc-6-P and of sample protein 
gave negative results, too. Thus, nuclei isolated 
from in vitro grown HD33 ascites cells contain 
neither glycogen nor glycogen synthase activity, in 
spite of the abundance of cytoplasmic glycogen 
particles present in the intact cells. 
The amount of glycogen found in homogenates 
of 4 days in vivo grown HD33 ELAT cells corre- 
sponds to ~3% of the values obtained from their 
in vitro counterpart, when compared on a mg pro- 
tein basis. The essentially nuclear deposition of 
the polysaccharide is reflected by the increased 
amount of glycogen per mg protein in isolated nu- 
clei. The specific activiiy of glycogen synthase in 
isolated nuclei of in vivo grown tumor cells is al- 
most 3-times higher than in cell homogenates, sug- 
gesting an association of the enzyme activity with 
the nuclear glycogen deposits. These results con- 
form with our earlier data on the subcellular dis- 
tribution of glycogen and glycogen synthase in 
HD33 ELAT cells 5 days after tumor transplanta- 
tion [2]. 
4. DISCUSSION 
This investigation of HD33 ascites tumor cells 
from an early stage of tumor development with 
chiefly nuclear glycogen storage, and of their in 
vitro growing counterpart with excessive but ex- 
clusively cytoplasmic glycogen deposition enabled 
us to determine whether nuclear glycogen synthase 
represents a fact or an artifact of preparation. An 
essential requirement was to exclude any artificial 
contamination of the isolated nuclei by cytoplas- 
mic glycogen particles and associated enzyme ac- 
tivities (cf. [ 11) which may cause considerable con- 
fusion. 
We used, with negative results, the most sensi- 
tive methods available to detect glycogen particles 
or glycogen synthase activity in preparations of nu- 
clei isolated from in vitro grown HD33 cells. Thus, 
the artifacts mentioned can be safely avoided by 
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an adequate nuclei isolation procedure, even in 
cells with excessive cytoplasmic glycogen deposi- 
tion. 
However, after applying the isolation procedure 
validated in this manner, high activity of glycogen 
synthase could be determined in nuclei of in vivo 
grown HD33 ELAT cells. This confirms our find- 
ing that glycogen storing nuclei of these tumor 
cells possess autochthonous nuclear glycogen syn- 
thase activity [2]. The presence or absence of 
glycogen synthase activity in the ascites cell nuclei 
depends, as shown here, on the growth conditions 
of the cells. 
The association of nuclear glycogen synthase ac- 
tivity with nuclear glycogen deposition, as ob- 
served in in vivo grown HD33 ELAT cells, sug- 
gests the presence of glycogen synthase also in the 
nuclei of other mammalian cells with nuclear 
glycogen storage (see citations in [1,2]). However, 
the possibility cannot be excluded that glycogen 
synthase might also be present in nuclei of cells 
which are virtually free of glycogen particles but 
exhibit high levels of glycogen synthase activity 
[7,81. 
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